Resonance Specialties Ltd
BSE:524218
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/S
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Enterprise Value to Sales (EV/S) ratio compares a company`s total enterprise value to its revenue. It shows how much investors are paying for each dollar of the company`s sales, including both equity and debt.
Valuation Scenarios
If EV/S returns to its 3-Year Average (1.3), the stock would be worth ₹104.23 (5% upside from current price).
| Scenario | EV/S Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 1.2 | ₹98.96 |
0%
|
| 3-Year Average | 1.3 | ₹104.23 |
+5%
|
| 5-Year Average | 0.6 | ₹50.77 |
-49%
|
| Industry Average | 1.8 | ₹146.71 |
+48%
|
| Country Average | 2.9 | ₹228.84 |
+131%
|
Forward EV/S
Today’s price vs future revenue
Peer Comparison
| Market Cap | EV/S | P/E | ||||
|---|---|---|---|---|---|---|
| IN |
R
|
Resonance Specialties Ltd
BSE:524218
|
1.1B INR | 1.2 | 12.9 | |
| US |
|
Sherwin-Williams Co
NYSE:SHW
|
80.3B USD | 3.9 | 31.3 | |
| JP |
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
13.3T JPY | 4.7 | 27.3 | |
| US |
|
Ecolab Inc
NYSE:ECL
|
75.3B USD | 5.1 | 36.3 | |
| JP |
Y
|
Yasuhara Chemical Co Ltd
TSE:4957
|
10.8T JPY | 0.8 | 10.5 | |
| CN |
|
Wanhua Chemical Group Co Ltd
SSE:600309
|
280.1B CNY | 1.6 | 21.3 | |
| CH |
|
Givaudan SA
SIX:GIVN
|
25.9B CHF | 3.9 | 24.2 | |
| DK |
|
Novozymes A/S
CSE:NZYM B
|
165.6B DKK | 9.4 | 54.8 | |
| IN |
|
Asian Paints Ltd
NSE:ASIANPAINT
|
2.4T INR | 6.7 | 61.4 | |
| US |
|
PPG Industries Inc
NYSE:PPG
|
24.1B USD | 1.8 | 15.3 | |
| US |
|
Albemarle Corp
NYSE:ALB
|
22B USD | 4.6 | -32.5 |
Market Distribution
| Min | 0 |
| 30th Percentile | 1.6 |
| Median | 2.9 |
| 70th Percentile | 5 |
| Max | 55 686.2 |
Other Multiples
Resonance Specialties Ltd
Glance View
Resonance Specialties Ltd. engages in the manufacturing and sale of chemicals. The company is headquartered in Mumbai, Maharashtra and currently employs 53 full-time employees. The firm is a manufacturer with backward integration, and it manufactures its own picolines and pyanopyridine. The firm operates through Chemical Manufacturing segment. The main activity of the Company is manufacturing of pyridine, picoline, cynopyridine and derivatives of the same. Its bulks drugs and nutritional products are toll converted. The firm is involved in multi products manufacturing and frictional distillation in batches and its overall average product cycle is approximately 2-4 months from the procurement till the disposal. The company is also focused on the production of value-added drug intermediates and active pharmaceutical ingredients (APIs). Its products offering include zinc picolinate, chromium picolinate, chromium polynicotinate, niacin and niacinamide. The firm also manufactures anti-tuberculosis products, such as Isoniazid.
